CareFusion (NYSE:CFN) said it closed out the $41 million settlement of a 2-year federal investigation into the marketing of its ChloraPrep antiseptic skin preparation wipes.
The San Diego-based medical device company received a U.S. Justice Dept. subpoena in April 2011, seeking information related to its relationships with healthcare professionals. Two more subpoenas connected to the case were issued, in Sepember 2011 and August 2012.
CareFusion and the Justice Dept. initially agreed to the settlement in April 2013. CareFusion completed its last payment at the beginning of this month, according to a regulatory filing.
“We are pleased to resolve this matter and are confident we have strong practices, processes and controls in place. We have made significant investments during the past several years to improve our quality and compliance systems, including our sales and marketing practices, and will continue to do so as part of our commitment to adhering to the highest standards and aligning with best global practices,” chairman & CEO Kieran T. Gallahue said in prepared remarks.
Earlier this month CareFusion closed its purchase of Totowa, N.J.-based Vital Signs from GE Healthcare (NYSE:GE) for $500 million.